In diabetic nephropathy, elevated expression of renal NADPH oxidase and eNOS resulted in oxidative stress with elevated lipid peroxidation, which was prevented following treatment with an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin receptor blocker (ARB) [13]. This evidence concerns the gene FMO5 and diabetic kidney disease.